<DOC>
	<DOCNO>NCT01809587</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy IQP-PO-101 regulating bowel movement frequency</brief_summary>
	<brief_title>IQP-PO-101 Regulation Bowel Movement Frequency</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<criteria>A subject must experience 2 4 bowel movement per week least 2 follow symptom precede 3 month ( selfreported ) : Excessive strain Lumpy hard stool Sensation anorectal obstruction A sense incomplete evacuation bowel movements A need digital manipulation facilitate evacuation Recorded 4 9 defecation 14day bowel movement diary runin period Subjects childbearing potential must agree use appropriate contraceptive method runin treatment period Commitment avoid use laxatives and/ medicinal products/ supplement may interfere bowel movement frequency runin treatment period Written inform consent . Known sensitivity ingredient device Any organic gastrointestinal disease , congenital otherwise Presence occult blood screen Constipation may druginduced Use laxative/ product help ease bowel movement within 7 day screen visit Constipation idiopathic constipation Presence factor ( ) , investigator 's judgement , preclude subject participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>